Suicidality in Parkinson’s Disease: A Case Control Study
Objective: To investigate suicidality in Parkinson's disease (PD) by a case control study Background: Depression, a risk factor for suicidality, is rather common in PD patients. Nevertheless,…Movement Disorders secondary to Spinal Cord Demyelination: an Evolving Spectrum
Objective: To describe the spectrum of movement disorders that result from spinal cord demyelination. Background: Spinal movement disorders (SMDs) secondary to cord demyelination are not…Assessing Bone Health in Parkinson’s – When and how?
Objective: To assess the impact of, and practicality of, assessing bone health routinely in people newly diagnosed with Parkinson’s disease in a South Wales University…Corticobasal syndrome due to brain tumor
Objective: To describe a case of a 60-year-old female that presented with cognitive decline and gait disorders for the last 7 years. Background: The…Effect of early AbobotulinumtoxinA (Dysport®) use after stroke on the time to reach reinjection criteria: asymptomatic versus symptomatic patients
Objective: To determine if early post-stroke (within 12 weeks) abobotulinumtoxinA (aboBoNT-A;Dysport®) injections delay appearance or progression of upper limb symptomatic spasticity. Background: Muscle tone changes…MitoQ and Reduced Glutathione Protects Against Dopamine Induced Brain Mitochondrial Electron Transport Chain Inhibition During Extended In Vitro Incubation: Involvement of Free Radicals and Quinone Products
Objective: To study the impact of MitoQ and GSH against DA induced rat brain mitochondrial electron transport chain inhibition during extended in vitro incubation. Background:…PROMESA: Progression Rate of MSA under EGCG Supplementation as anti-Aggregation-Approach – evaluation of serious adverse events
Objective: In the PROMESA trial (ClinicalTrials Identifier: NCT02008721) Epigallocatechingallate (EGCG) a catechine that prevents pathological protein aggregation in vitro and can be purified from green…Disability-Adjusted Life Years (DALY) in X-linked Dystonia Parkinsonism
Objective: To evaluate the Disability-Adjusted Life Years in X-linked Dystonia Parkinsonism patients at the Health Centrum, Movement Disorders Clinic, Roxas City Capiz, Philippines. Background: The disability-adjusted…Striatal Cholinergic Neurons in Cervical Dystonia
Objective: To determine if there is cholinergic neuronal loss in the putamen in cervical dystonia. Background: The etiology of cervical dystonia is unknown. Striatal cholinergic…Clinical profile of patients with blepharospasm
Objective: To present the clinical profile of 61 patients with blepharospasm who were treated with onabotulinum toxin injections. Background: Blepharospasm is a focal dystonia that…
- « Previous Page
- 1
- …
- 112
- 113
- 114
- 115
- 116
- …
- 155
- Next Page »